Cédric Rossi

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Laëtitia Vercellino, Roberta Di Blasi, Salim Kanoun et al. · Blood Advances · 2020 · 404 citations · Full text

Medicine, Oncology, Cell Therapy +16

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

Livio Pagano, Jon Salmanton‐García, Francesco Marchesi et al. · Journal of Hematology & Oncology · 2021 · 318 citations · Full text

Medicine, Hematology, Infectious Diseases +13

Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma

Salim Kanoun, Cédric Rossi, Alina Berriolo-Riedinger et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 177 citations

Veterinary Medicine, Oncology, Neoplasia +6

Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with <scp>non‐Hodgkin</scp> lymphoma treated with B‐cell depleting immunotherapy

Rémy Duléry, Sylvain Lamure, Marc Delord et al. · American Journal of Hematology · 2021 · 157 citations · Full text

Medicine, Internal Medicine, Oncology +13

Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial

Steven Le Gouill, Franck Morschhauser, David Chiron et al. · Blood · 2020 · 129 citations · Full text

Medicine, Hematology, Oncology +12